Diana joined Novo Seeds in April 2016.
Prior to joining Novo, Diana was a Business Development Manager at Chiesi where she was responsible for Orphan Diseases, Neonatology and Special care in-licensing and M&A. She also brings experience from working in the UK based biotech company hVIVO, where she was part of building an R&D division, including a fundraising and a company acquisition. Prior to this Diana worked in Healthcare Investment Banking in London.
Diana holds a PhD degree from University of Oxford in Radiation Oncology. She obtained her licentiate and undergraduate degree from Stockholm University and Karolinska Institute during which time she also worked as an IRTA at NIH, USA.